AnodyneWiki

Caffeine

Caffeine
Caffeine
Salts
[]
Caffeine citrate
Caffeine citrate
Caffeine salicylate
Caffeine salicylate
Caffeine monohydrate
Caffeine monohydrate
Molecular structure drawn from PubChem coordinates
Rotamer
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
Molecular mass194.19 g/mol [1]
AppearanceWhite, prismatic crystals [1]
OdorOdorless [1]
TasteBitter taste [1]
Density1.23 at 64 °F (NTP, 1992) - Denser than water; will sink [1]
Melting point460 °F (NTP, 1992) [1]
Boiling point352 °F at 760 mmHg (sublimes) (NTP, 1992) [1]
DecompositionWhen heated to decomposition, it emits toxic fumes of /nitrogen oxides/. [1]
Solubility10 to 50 mg/mL at 73 °F (NTP, 1992) [1]
Predicted LogP-0.1 [1]
Structural Identifiers
[]
Molecular formulaC8H10N4O2
IUPAC name1,3,7-trimethylpurine-2,6-dione
SMILESCN1C=NC2=C1C(=O)N(C(=O)N2C)C
InChIInChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
InChIKeyRYYVLZVUVIJVGH-UHFFFAOYSA-N
CAS number58-08-2
UNII3G6A5W338E
PubChem CID2519
Pharmacokinetics[]
Onset45 minutes–1 hour[3]
Elimination half-lifeAdults: 3–7 hours, Infants (full term): 8 hours, Infants (premature): 100 hours[4]
Duration of action3–4 hours[5]
MetabolismPrimary: CYP1A2, Minor: CYP2E1, CYP3A4,, CYP2C8, CYP2C9
ExcretionUrine (100%)
Routes of administrationCommon: By mouth Medical: Intravenous , Uncommon: Insufflation, rectal, transdermal, topical, buccal, sublingual, inhalation
Dependence liabilityPhysical: Low–moderate (9–30%) , Psychological: Low–moderate[6]
Addiction liabilityNone[7][8]
Toxicity
[]
Mouse:
- Oral: 127 mg/kg
Rat:
- ip: 260 mg/kg
- oral: 192 mg/kg
- rectal: 300 mg/kg
- iv: 105 mg/kg
 [1]

Caffeine (also known as Guaranine, 1,3,7-Trimethylxanthine, Methyltheobromine, Theine, Thein, Cafeina, Caffein, Cafipel, Koffein or Mateina) is a depressant substance of the xanthine class.

It is a constituent of coffea.

Chemistry

Salts []

Caffeine is typically found in the form of its citrate, salicylate and monohydrate salts.

 []

Caffeine is achiral.

Caffeine matches Lipinski's rule of five.

There are currently 10 reagent-interactions on

ReagentColor changeDescription
Marquisno color change
Meckeno color change
Mandelinno color change
Liebermannlight yellow / yellow
Froehdeno color change
Robadopeno pink color change
Simon'sno blue color change
Ehrlichno color change
Hofmannno color change
Scottno color change

Pharmacology

Mechanism of action []

The mechanism of action of caffeine is complex, as it impacts several body systems, which are listed below. The effects as they relate to various body systems are described as follows: **General and cellular actions** Caffeine exerts several actions on cells, but the clinical relevance is poorly understood. One probable mechanism is the inhibition of nucleotide phosphodiesterase enzymes, adenosine receptors, regulation of calcium handling in cells, and participates in adenosine receptor antagonism. Phosphodiesterase enzymes regulate cell function via actions on second messengers cAMP and cGMP. This causes lipolysis through activation of hormone-sensitive lipases, releasing fatty acids and glycerol. **Respiratory** The exact mechanism of action of caffeine in treating apnea related to prematurity is unknown, however, there are several proposed mechanisms, including respiratory center stimulation in the central nervous system, a reduced threshold to hypercapnia with increased response, and increased consumption of oxygen, among others. The blocking of the adenosine receptors enhances respiratory drive via an increase in brain medullary response to carbon dioxide, stimulating ventilation and respiratory drive, while increasing contractility of the diaphragm. **Central nervous system** Caffeine demonstrates antagonism of all 4 adenosine receptor subtypes (A1, A2a, A2b, A3) in the central nervous system. Caffeine's effects on alertness and combatting drowsiness are specifically related to the antagonism of the A2a receptor. **Renal system** Caffeine has diuretic effects due to is stimulatory effects on renal blood flow, increase in glomerular filtration, and increase in sodium excretion. **Cardiovascular system** Adenosine receptor antagonism at the A1 receptor by caffeine stimulates inotropic effects in the heart. Blocking of adenosine receptors promotes catecholamine release, leading to stimulatory effects occurring in the heart and the rest of the body. In the blood vessels, caffeine exerts direct antagonism of adenosine receptors, causing vasodilation. It stimulates the endothelial cells in the blood vessel wall to release nitric oxide, potentiating blood vessel relaxation. Catecholamine release, however, antagonizes this and exerts inotropic and chronotropic effects on the heart, ultimately leading to vasoconstriction. Finally, caffeine is shown to raise systolic blood pressure measurements by 5 to 10 mmHg when it is not taken regularly, versus no effect in those who consume it regularly. The vasoconstricting effects of caffeine are beneficial in migraines and other types of headache, which are normally caused by vasodilation in the brain. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

inhibition / metabolism37
shared target8 (1 contraindicated)
shared target8
shared target7
shared target7
shared target7
shared target7
shared target7
shared target7
shared target7
metabolism4
shared target3 (1 contraindicated)
shared target2

Medical side effects []

51 side effects listed on drug labels in (caffeine).

  • Dermatitis
  • Rash
  • Sepsis
  • Necrotising colitis
  • Necrotising enterocolitis neonatal
  • Acidosis
  • Disseminated intravascular coagulation
  • Dyspnoea
  • Gastritis
  • Gastrointestinal haemorrhage
  • Haemorrhage
  • Haemoglobin
  • Pulmonary oedema
  • Renal failure
  • Retinopathy of prematurity
  • Skin disorder
  • Impaired healing
  • Injury
  • Dry skin
  • Cerebral haemorrhage
  • Immune system disorder
  • Infection
  • Deafness
  • Failure to thrive
  • Gastrointestinal disorder
  • Cardiac disorder
  • Hyperglycaemia
  • Hypersensitivity
  • Hypertension
  • Hypoglycaemia
  • Irritability
  • Nervous system disorder
  • Convulsion
  • Tachycardia
  • Agitation
  • Blood creatinine increased
  • Haemoglobin decreased
  • Malnutrition
  • Brain injury
  • Stroke volume increased
  • Nervousness
  • Feeling jittery
  • Hypercalcaemia
  • Blood sodium increased
  • Infestation
  • Infusion site phlebitis
  • Infusion site inflammation
  • Urine output increased
  • Thyroxine decreased
  • Brain hypoxia
  • Regurgitation

Indications

  • Apnoea
  • Primary apnea of premature newborns

Subjective effects []

0xea / Caffeine []
Routes:
  • Oral (100 - 1700mg)
    Onset: 30 - 45 m
    Duration: 6 - 12 h
  • Insufflated (60 - 120mg)
  • Intravenous
Forms:
  • Freebase
  • Citrate
Indication:Effects:Tolerance:
  • tolerance builds from daily usage over weeks, months to years leading to dosage escalation.
  • effects remain reachable with dosage escalation.
a1ko / Caffeine []
Routes:
  • Oral
  • Rectal
  • Insufflated (65mg)
  • Intravenous
alina / Caffeine []
Routes:
  • Oral (30 - 400mg)
bonzi / Caffeine []
Routes:
  • Oral (60 - 400mg)
emily / Caffeine []
Routes:
  • Oral (20 - 171mg)
magnus / Caffeine []
Routes:
  • Oral (400mg)
Forms:
  • Freebase
Effects:
nervewing / Caffeine []
ninerik / Caffeine []
Routes:
  • Oral (35 - 680mg)
Classes:Source:
  • Energy drinks
  • Coffee
  • Tea
  • Bulk.com 200mg tablets
Indication:Effects:Notes:
  • Awful awful awful stimulant
Pilz / Caffeine []
Routes:
  • Oral (20 - 200mg)
  • Insufflated (20 - 60mg)
Forms:
  • Freebase
Source:
  • Coffee
  • Energy drink
  • Leidapharm Paracetamol 500mg + Caffeine 50mg tablets
  • Bulk.com 200mg caffeine tablets
  • Slovakian pharmacy: Caffetin tablets
Effects:
vivi / Caffeine []
Routes:
  • Oral (10 - 280mg)
  • Insufflated (20 - 35mg)

Experience reports

Erowid

There are currently 30 experience reports involving caffeine on : []

Reddit

There are currently 50 trip reports involving caffeine on : []

 []

  • Australia: Caffeine is Unscheduled.
  • Brazil: Caffeine is Unscheduled.
  • Canada: Caffeine is Unscheduled.
  • Germany: Caffeine is Unscheduled.
  • New Zealand: Caffeine is Unscheduled.
  • United Kingdom: Caffeine is a GSL.
  • United States: Caffeine is Unscheduled.
  • United Nations: Caffeine is Unscheduled.
  • Other: Caffeine is a CN: OTC, SE: Unscheduled In general legal for all uses.[9]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 2519, Caffeine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2519
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Caffeine. UNII: 3G6A5W338E. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3G6A5W338E
  3. Institute of Medicine (US) Committee on Military Nutrition Research. Pharmacology of Caffeine. National Academies Press (US). 2001. https://www.ncbi.nlm.nih.gov/books/NBK223808/
  4. Caffeine. DrugBank. 16 September 2013. http://www.drugbank.ca/drugs/DB00201#pharmacology
  5. Poleszak E, Szopa A, Wyska E, Kukuła-Koch W, Serefko A, Wośko S, Bogatko K, Wróbel A, Wlaź P. Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice. Pharmacological Reports. February 2016; 68(1):56–61. PMID 26721352. https://ruj.uj.edu.pl/xmlui/handle/item/101035
  6. Griffiths RR, Chausmer AL. Caffeine as a model drug of dependence: Recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 2000; 20(5):223–231. PMID 11326548.
  7. Quadra GR, Brovini EM, dos Santos JA, Paranaíba JR. Handbook of Substance Misuse and Addictions. Springer International Publishing. 2022. https://doi.org/10.1007/978-3-030-67928-6_78-1
  8. Nestler EJ, Kenny PJ, Russo SJ, Schaefer A. Nestler, Hyman & Malenka's Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. McGraw Hill. 2020.
  9. Koffein Viatris, Tablett 100 mg. Läkemedelsverket. https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel/19730302000030/koffein-viatris-100-mg-tablett#:~:text=Vissa%20f%C3%B6rpackningar%20receptbelagda

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 07:07:42
drugsprook2026-11-20 07:07:38
erowidok2026-11-20 07:07:39
gsrsok2026-11-20 07:07:40
hmdbmissing (hmdb.ca refused automated access to HMDB0001847)2026-11-20 07:07:38
keggok2026-11-20 07:07:41
pubchemok2026-11-20 07:07:37
redditok2026-11-20 07:07:38
siderok2026-11-20 07:07:38
structureok2026-11-20 07:07:38
wikipediaok2026-11-20 07:07:38